Low-dose venlafaxine-induced severe rhabdomyolysis: A case report

General Hospital Psychiatry

Volumn 34, Issue 4, 2012, Pages 436.e5-436.e7

  Huang, Shiau Shian ^a   Yang, Hsin Yu ^a   Lin, Yu Chen ^a   Chan, Chin Hong ^a,b,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Antidepressant; Depression; Low dose; Rhabdomyolysis; Venlafaxine

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BICARBONATE; CREATINE KINASE; SERTRALINE; VALPROIC ACID; VENLAFAXINE;

ADULT; ARTICLE; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HELP SEEKING BEHAVIOR; HEMATURIA; HUMAN; LENGTH OF STAY; LOW DRUG DOSE; MEDICAL HISTORY; OUTCOME ASSESSMENT; RHABDOMYOLYSIS; SOCIAL INTERACTION; URINALYSIS;

EID: 84862761429     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2012.01.016     Document Type: Article

References (13)

1. Pacher P., Kecskemeti V. Trends in the development of new antidepressants. Is there a light at the end of the tunnel?. Curr Med Chem 2004, 11:925-943.
2. Stahl S.M. Neuroscientific basis and practical applications. Stahl's essential psychopharmacology 2008, 544. Cambridge University, The United States of America. 3rd ed. S.M. Stahl (Ed.).
3. Peano C., Leikin J.B., Hanashiro P.K. Seizures, ventricular tachycardia, and rhabdomyolysis as a result of ingestion of venlafaxine and lamotrigine. Ann Emerg Med 1997, 30:704-708.
4. Hanekamp B.B., Zijlstra J.G., Tulleken J.E., et al. Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report. Neth J Med 2005, 63:316-318.
5. Kaufman K.R., Levitt M.J., Schiltz J.F., Sunderram J. Neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: case analysis. Ann Clin Psychiatry 2006, 18:201-204.
6. Pascale P., Oddo M., Pacher P., Augsburger M., Liaudet L. Severe rhabdomyolysis following venlafaxine overdose. Ther Drug Monit 2005, 27:562-564.
7. Stahl S.M. Neuroscientific basis and practical applications. Stahl's essential psychopharmacology 2008, 547-550. Cambridge University, The United States of America. 3rd ed. S.M. Stahl (Ed.).
8. Wilson A.D., Howell C., Waring W.S. Venlafaxine ingestion is associated with rhabdomyolysis in adults: a case series. J Toxicol Sci 2007, 32:97-101.
9. Lu T.C., Chu P.L., Wu C.S., Tsai K.C., Chen W.J. Neuroleptic malignant syndrome after the use of venlafaxine in a patient with generalized anxiety disorder. J Formos Med Assoc 2006, 105:90-93.
10. Rajapakse S., Abeynaike L., Wickramarathne T. Venlafaxine-associated serotonin syndrome causing severe rhabdomyolysis and acute renal failure in a patient with idiopathic Parkinson disease. J Clin Psychopharmacol 2010, 30:620-622.
11. Tanaka E. Clinically significant pharmacokinetic drug interactions between antiepileptic drugs. J Clin Pharm Ther 1999, 24:87-92.
12. Micromedex 2.0. Healthcare Series. Greenwood Village (CO): Thomson Reuters (Healthcare) Inc. Last accessed Jan 27,2012. http://www.thomsonhc.com/micromedex2/librarian.
13. Stahl S.M. Neuroscientific basis and practical applications. Stahl's essential psychopharmacology 2008, 604-605. Cambridge University, The United States of America. 3rd ed. S.M. Stahl (Ed.).